Literature DB >> 2117633

HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.

A Herman1, G Croteau, R P Sekaly, J Kappler, P Marrack.   

Abstract

Staphylococcal enterotoxins (SEs) have been shown to bind to major histocompatibility complex (MHC) class II proteins and stimulate T cells in a V beta-specific manner, and these V beta specificities for various SEs have been well documented in mice and humans. This study was undertaken in order to examine the ability of human class II molecules to present SEs to human and murine T cell hybridomas. Using a panel of transfectants expressing individual HLA class II antigens, we have shown that HLA-DR alleles differ in their ability to bind and present SEs. Since the HLA-DR proteins share a common alpha chain, these results indicate that the polymorphic beta chain plays an important role in SE binding and presentation to T cells. In addition, we have shown that human class II isotypes markedly differ in their ability to present SEs. The results of this study should provide information on the region of MHC class II molecules that interacts with foreign, and perhaps self, super-antigens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117633      PMCID: PMC2188560          DOI: 10.1084/jem.172.3.709

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

2.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Stimulation of B10.BR T cells with superantigenic staphylococcal toxins.

Authors:  J E Callahan; A Herman; J W Kappler; P Marrack
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

6.  Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.

Authors:  L W Arnold; N J LoCascio; P M Lutz; C A Pennell; D Klapper; G Haughton
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

7.  Further characterization of HLA-DS molecules: implications for studies assessing the role of human Ia molecules in cell interactions and disease susceptibility.

Authors:  S M Goyert; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  82 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Recombinant Staphylococcus aureus exfoliative toxins are not bacterial superantigens.

Authors:  L R Plano; D M Gutman; M Woischnik; C M Collins
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 3.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 4.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

5.  Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

Authors:  D R Karp; R N Jenkins; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Selective manipulation of the human T-cell receptor repertoire expressed by thymocytes in organ culture.

Authors:  M Merkenschlager; A G Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Authors:  B C Cole; A D Sawitzke; E A Ahmed; C L Atkin; C S David
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

8.  Expression of the identical V beta gene in human T-cell clones does not confer the same pattern of responsiveness to bacterial enterotoxins.

Authors:  S Quaratino; A Verhoef; M Kahan; M Londei
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

9.  Recombinant epidermolytic (exfoliative) toxin A of Staphylococcus aureus is not a superantigen.

Authors:  B Fleischer; C J Bailey
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

10.  V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.

Authors:  Y X Zhao; U Brunsberg; R Holmdahl; A Tarkowski
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.